This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2006 Sep;3(9):472-3.

doi: 10.1038/ncpuro0559.

A combination of intravesical BCG [corrected] and [corrected] electromotive mitomycin for high-risk superficial bladder cancer

Ashish M Kamat¹, Colin P N Dinney

Affiliations

PMID: 16964186
DOI: 10.1038/ncpuro0559

Comment

A combination of intravesical BCG [corrected] and [corrected] electromotive mitomycin for high-risk superficial bladder cancer

Ashish M Kamat et al. Nat Clin Pract Urol. 2006 Sep.

. 2006 Sep;3(9):472-3.

doi: 10.1038/ncpuro0559.

Authors

Ashish M Kamat¹, Colin P N Dinney

Affiliation

¹ Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. akamat@mdanderson.org

PMID: 16964186
DOI: 10.1038/ncpuro0559

Erratum in

Nat Clin Pract Urol. 2006 Nov;3(11):623

No abstract available

PubMed Disclaimer

Comment on

Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: a randomised controlled trial.
Di Stasi SM, Giannantoni A, Giurioli A, Valenti M, Zampa G, Storti L, Attisani F, De Carolis A, Capelli G, Vespasiani G, Stephen RL. Di Stasi SM, et al. Lancet Oncol. 2006 Jan;7(1):43-51. doi: 10.1016/S1470-2045(05)70472-1. Lancet Oncol. 2006. PMID: 16389183 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.